- Home
- BMRN vs IPG Comparison
BMRN vs IPG Comparison
Compare BMRN & IPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- IPG
- Stock Information
- Founded
- BMRN 1996
- IPG 1902
- Country
- BMRN United States
- IPG United States
- Employees
- BMRN N/A
- IPG N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- IPG Advertising
- Sector
- BMRN Health Care
- IPG Consumer Discretionary
- Exchange
- BMRN Nasdaq
- IPG Nasdaq
- Market Cap
- BMRN 10.0B
- IPG 9.9B
- IPO Year
- BMRN 1999
- IPG N/A
- Fundamental
- Price
- BMRN $52.47
- IPG $26.79
- Analyst Decision
- BMRN Buy
- IPG Buy
- Analyst Count
- BMRN 18
- IPG 6
- Target Price
- BMRN $93.71
- IPG $31.10
- AVG Volume (30 Days)
- BMRN 2.2M
- IPG 7.1M
- Earning Date
- BMRN 10-28-2025
- IPG 10-21-2025
- Dividend Yield
- BMRN N/A
- IPG 5.06%
- EPS Growth
- BMRN 154.69
- IPG N/A
- EPS
- BMRN 3.40
- IPG 1.18
- Revenue
- BMRN $3,063,608,000.00
- IPG $8,846,600,000.00
- Revenue This Year
- BMRN $13.35
- IPG N/A
- Revenue Next Year
- BMRN $9.18
- IPG $2.71
- P/E Ratio
- BMRN $15.44
- IPG $22.06
- Revenue Growth
- BMRN 18.36
- IPG N/A
- 52 Week Low
- BMRN $51.57
- IPG $22.51
- 52 Week High
- BMRN $73.51
- IPG $33.05
- Technical
- Relative Strength Index (RSI)
- BMRN 38.26
- IPG 52.67
- Support Level
- BMRN $51.79
- IPG $25.90
- Resistance Level
- BMRN $55.39
- IPG $27.56
- Average True Range (ATR)
- BMRN 1.36
- IPG 0.78
- MACD
- BMRN -0.11
- IPG -0.03
- Stochastic Oscillator
- BMRN 19.28
- IPG 38.53
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About IPG Interpublic Group of Companies Inc. (The)
Interpublic Group is among the world's largest advertising holding companies based on annual revenue. It provides traditional advertising services along with digital and other services, such as public relations, through various acquisitions. IPG has made these services available in over 100 countries. The company generates about 65% of revenue in the US and 17% in the UK and Europe.